chad63 me-trap

Vaccineexperimental

Clinical trial activity

11 trials · 6 clinical orgs · 0 marketing orgs

Phase 1
11
Phase 2
6
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2007 (NCT00890019)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • adch63 me-trap
  • chad63 me-trap

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05441410Phase 1/Phase 2 (Phase 2)Oct 1, 2022Sanaria Inc., University of Oxford, University of Tuebingen
NCT03707353Phase 1/Phase 2 (Phase 2)Oct 30, 2018University of Oxford
NCT02905019Phase 1/Phase 2 (Phase 2)Aug 1, 2016University of Oxford
NCT01450293Phase 1Oct 1, 2011European and Developing Countries Clinical Trials Partnership (EDCTP), Medical Research Council, The Gambia, University of Oxford
NCT01364883Phase 1Jul 1, 2011University of Oxford
NCT01373879Phase 1Jun 1, 2010European and Developing Countries Clinical Trials Partnership (EDCTP), Medical Research Council, The Gambia, University of Oxford
NCT01142765Phase 1/Phase 2 (Phase 2)Jun 1, 2010University of Oxford
NCT01379430Phase 1Jun 1, 2010European and Developing Countries Clinical Trials Partnership (EDCTP), Kenya Medical Research Institute, University of Oxford
NCT01003314Phase 1/Phase 2 (Phase 2)Nov 1, 2009University of Oxford
NCT00890760Phase 1/Phase 2 (Phase 2)Mar 1, 2009University of Oxford
NCT00890019Phase 1Jul 1, 2007University of Oxford
Showing 11 of 11 trials
Page 1 / 1

Organizations

Research & Development (6)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of OxfordAcademic/Hospital111022007
European and Developing Countries Clinical Trials Partnership (EDCTP)Academic/Hospital3012010
Medical Research Council, The GambiaGovernment2012010
Kenya Medical Research InstituteAcademic/Hospital1012010
Sanaria Inc.For profit1012022
University of TuebingenAcademic/Hospital1112022
6 organizations
Page 1 / 1